BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Shukra Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524632
ISIN Demat
INE551C01044
Book Value (Rs)
2.1836772
NSE Symbol
SHUKRAPHAR
Divident Yield %
0.02
Market Cap
(Rs In Cr.)
1,939
P/E (TTM)
53.79
EPS (TTM)
0.82
Face Value
(Rs)
1
Date Heading
18-Aug-26 Shukra Pharmaceuticals to conduct board meeting
17-Aug-26 Shukra Pharmaceuticals to conduct board meeting
12-Aug-26 Shukra Pharmaceuticals consolidated net profit rises 1158.25% in the J
07-Aug-26 Shukra Pharmaceuticals schedules board meeting
07-Aug-26 Shukra Pharmaceuticals revises board meeting date
31-Jul-26 Shukra Pharmaceuticals to convene board meeting
11-Jun-26 Shukra Pharmaceuticals to conduct EGM
06-Jun-26 Shukra Pharmaceuticals to convene board meeting
08-May-26 Board of Shukra Pharmaceuticals recommends final dividend
08-May-26 Shukra Pharmaceuticals reports consolidated net loss of Rs 1.72 crore
30-Apr-26 Shukra Pharmaceuticals to discuss results
07-Mar-26 Shukra Pharmaceuticals fixes board meeting date
04-Feb-26 Shukra Pharmaceuticals standalone net profit rises 544.30% in the Dece
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)